US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.
Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than ‘games and game rules’.
IP Australia has revoked four innovation gaming patents held by Aristocrat Technologies related to the use of configurable symbols in a game, saying the inventions didn’t amount to anything other than games and game rules.
CSIRO has won a challenge to an application for a mining patent filed by mining giant Rio Tinto, with an IP Australia delegate finding no patentable subject matter could be claimed.
The Australian Patent Office has invalidated two insecticide patents by Bayer on a challenge by rival Syngenta, with a delegate of the agency ruling the inventions’ claims were obvious.